The Global Health Impact Index: Promoting Global Health

Millions of people cannot access essential medicines they need for deadly diseases like malaria, tuberculosis (TB) and HIV/AIDS. There is good information on the need for drugs for these diseases but until now, no global estimate of the impact drugs are having on this burden. This paper presents a model measuring companies’ key malaria, TB and HIV/AIDS drugs’ consequences for global health (global-health-impact.org). It aggregates drugs’ impacts in several ways–by disease, country and originator-company. The methodology can be extended across diseases as well as drugs to provide a more extensive picture of the impact companies’ drugs are having on the global burden of disease. The study suggests that key malaria, TB and HIV/AIDS drugs are, together, ameliorating about 37% of the global burden of these diseases and Sanofi, Novartis, and Pfizer’s drugs are having the largest effect on this burden. Moreover, drug impacts vary widely across countries. This index provides important information for policy makers, pharmaceutical companies, countries, and other stake-holders that can help increase access to essential medicines.     

Transforming Global Health with Mobile Technologies and Social Enterprises: Global Health and Innovation Conference

More than 2,000 people convened for the ninth annual Global Health and Innovation Conference at Yale University on April 21-22, 2012. Participants discussed the latest innovations, ideas in development, lessons learned, opportunities and challenges in global health activities. Several themes emerged, including the important role of frontline workers, strengthening health systems, leveraging social media, and sustainable and impact-driven philanthropy. Overall, the major outcome of the conference was the increased awareness of the potential of mobile technologies and social enterprises in transforming global health. Experts warned that donations and technological advances alone will not transform global health unless there are strong functioning health infrastructures and improved workforce. It was noted that there is a critical need for an integrated systems approach to global health problems and a need for scaling up promising pilot projects. Lack of funding, accountability, and sustainability were identified as major challenges in global health.     

Global Environmental Change and Population Health: Progress and Challenges

Escalating global environmental change (GEC) over the past century has been driven largely by rapid industrialization, population growth, overconsumption of natural resources, and associated waste disposal challenges, as well as the inappropriate uses of technology. These changes are already having and will increasingly continue to have significant impacts on human health and well-being. How to tackle these issues is an important challenge to scientists, policy-makers, and the general public. Scientific consensus now exists that GEC and population health are linked, even though the details and mechanisms underlying this link remain to be both explicated and quantified. In this article we provide an overview of progress and challenges in the area of GEC and population health since the late 1980s, highlighting some of the main landmarks in this area and recommending directions for future research.